Daily News Podcast

Novel formulation for childhood ADHD

Publish date: November 20, 2018

 

A novel formulation of methylphenidate could provide morning relief to pediatric patients with attention-deficit hyperactivity disorder. Also today, CARE MD protocol could help treat somatic disorders, children with poor cardiorespiratory fitness have a higher risk of type 2 diabetes, and ganglion stimulation boosts cerebral blood flow and improves stroke outcomes.
Amazon Alexa
Apple Podcasts
Google Podcasts

Recommended Reading

Hypertension and CVD risk for young adults
MDedge Neurology
Biomarkers and concussions
MDedge Neurology
Samuel Shem: Part II
MDedge Neurology
Brain stimulation device improved fluency in persons who stutter
MDedge Neurology
Trump rule and ACA contraception
MDedge Neurology
Heart failure and sacubiril/valsartan
MDedge Neurology
Vitamin D, fish out, and primary prevention
MDedge Neurology
USPSTF: screen for ‘unhealthy’ alcohol use
MDedge Neurology
Obesity curbs decades of CVD progress
MDedge Neurology
Physical fitness guidelines from HHS
MDedge Neurology